|
Real-time Estimate
Cboe BZX
00:34:38 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 64.00 USD | -1.61% |
|
-0.89% | -2.40% |
| 11:59pm | Supplements brand Rho Nutrition explores sale, sources say | RE |
| 11:44pm | Global markets live: Visa, Meta, Amazon, Apple, JetBlue… |  |
Company Valuation: Unilever PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 120,277 | 119,234 | 109,432 | 136,147 | 121,203 | 125,819 | - | - |
| Change | - | -0.87% | -8.22% | 24.41% | -10.98% | 3.81% | - | - |
| Enterprise Value (EV) 1 | 145,787 | 142,910 | 133,089 | 160,666 | 144,279 | 149,736 | 148,845 | 148,276 |
| Change | - | -1.97% | -6.87% | 20.72% | -10.2% | 3.78% | -0.59% | -0.38% |
| P/E | 20.2x | 15.8x | 17.1x | 24x | 21.5x | 19.5x | 18.1x | 17x |
| PBR | 7.03x | 6.27x | 6.05x | 6.81x | 7.82x | 7.91x | 7.28x | 6.65x |
| PEG | - | 0.5x | -1.2x | -2.3x | 40.28x | 1.2x | 2.32x | 2.8x |
| Capitalization / Revenue | 2.29x | 1.98x | 1.84x | 2.24x | 2.4x | 2.43x | 2.33x | 2.25x |
| EV / Revenue | 2.78x | 2.38x | 2.23x | 2.64x | 2.86x | 2.89x | 2.76x | 2.65x |
| EV / EBITDA | 12.8x | 12.5x | 11.6x | 12.5x | 12.7x | 12.8x | 12.1x | 11.5x |
| EV / EBIT | 15.1x | 14.8x | 13.4x | 14.4x | 14.3x | 14.4x | 13.6x | 13x |
| EV / FCF | 22.8x | 25.3x | 18.8x | 23.2x | 24.4x | 23.5x | 21.2x | 20.3x |
| FCF Yield | 4.39% | 3.96% | 5.33% | 4.31% | 4.1% | 4.26% | 4.73% | 4.92% |
| Dividend per Share 2 | 1.954 | 1.883 | 1.921 | 1.979 | 1.82 | 1.895 | 1.989 | 2.093 |
| Rate of return | 3.7% | 3.55% | 3.9% | 3.2% | 3.27% | 3.24% | 3.4% | 3.58% |
| EPS 2 | 2.61 | 3.364 | 2.88 | 2.576 | 2.59 | 3.001 | 3.235 | 3.431 |
| Distribution rate | 74.8% | 56% | 66.7% | 76.8% | 70.3% | 63.1% | 61.5% | 61% |
| Net sales 1 | 52,444 | 60,073 | 59,604 | 60,761 | 50,503 | 51,791 | 53,959 | 55,910 |
| EBITDA 1 | 11,382 | 11,408 | 11,510 | 12,803 | 11,394 | 11,734 | 12,334 | 12,876 |
| EBIT 1 | 9,636 | 9,683 | 9,931 | 11,179 | 10,084 | 10,395 | 10,934 | 11,437 |
| Net income 1 | 6,049 | 7,642 | 6,487 | 5,744 | 9,469 | 6,494 | 6,686 | 7,288 |
| Net Debt 1 | 25,510 | 23,676 | 23,657 | 24,519 | 23,076 | 23,917 | 23,026 | 22,457 |
| Reference price 2 | 52.85 | 53.04 | 49.26 | 61.87 | 55.70 | 58.43 | 58.43 | 58.43 |
| Nbr of stocks (in thousands) | 2,275,903 | 2,247,919 | 2,221,344 | 2,200,509 | 2,175,828 | 2,153,300 | - | - |
| Announcement Date | 10/2/22 | 9/2/23 | 8/2/24 | 13/2/25 | 12/2/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.39x | 4.4x | 16.16x | 2.77% | 369B | |
| 32.8x | 4.98x | 20.65x | 1.8% | 255B | |
| 19.47x | 2.89x | 12.76x | 3.24% | 140B | |
| 25.42x | 3.74x | 15.74x | 2.34% | 73.48B | |
| 57.75x | 8.28x | 31.91x | 0.26% | 52.06B | |
| 37.7x | 6.07x | 26.38x | 2.48% | 44.97B | |
| 37.14x | 2.78x | 15.46x | 1.43% | 39.2B | |
| 20.47x | 2.85x | 11.88x | 4.34% | 37.32B | |
| 18.6x | 2.49x | 11.53x | 4.72% | 36.28B | |
| Average | 30.30x | 4.27x | 18.05x | 2.6% | 116.41B | |
| Weighted average by Cap. | 27.87x | 4.37x | 17.65x | 2.5% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ULVR Stock
- UL Stock
- Valuation Unilever PLC
Select your edition
All financial news and data tailored to specific country editions
